Health Technology Assessment

Volume 13, number 28.
A randomised controlled trial to compare minimally invasive glucose monitoring devices to conventional monitoring in the management of insulin-treated diabetes mellitus (MITRE)
http://www.hta.nhs.uk/project/1306.asp

Diabetes Type 2 Horizon Scanning Bulletin

The Diabetes Type 2 Horizon Scanning Bulletin has now been published at
http://diabetestype2nwpctl.wordpress.com/
To subscribe to future issues of the newsletter, visit
http://feedburner.google.com/fb/a/mailverify?uri=DiabetesType2HorizonScanning&loc=en_US
and input your email address and the verification code.

New England Journal of Medicine

To coincide with a presentation at the American Diabetes Association
69th Scientific Sessions, the following articles were published at
NEJM.org on June 7, 2009. They will appear in the June 11, 2009,
issue of the Journal.

Original Article: A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
The BARI 2D Study Group
Editorial: Diabetes with Coronary Disease -- A Moving Target amid Evolving Therapies?
W.E. Boden and D.P. Taggart

Clinical effectiveness and cost effectiveness of long acting insulin analogues for diabetes

The clinical effectiveness and cost effectiveness of long acting insulin analogues for diabetes
Read the complete summary
NICE has recommended insulin glargine as an option for people with type 1 diabetes. For people with type 2 diabetes who need to take insulin, NICE has recommended that insulin glargine should be an option only if the person:
needs help with his or her insulin injections from a carer or healthcare professional, or
has repeated and unpleasant hypoglycaemic episodes that significantly affect his or her way of life, or would otherwise need to have two insulin injections to maintain background levels every day as well as having to take other diabetes medicines orally.

The recommendations in this technology appraisal relating to type 2 diabetes have been replaced by recommendations in the Diabetes - type 2 (update) clinical guideline published in May 2008. Please note that the recommendations in this technology appraisal relating to type 1 diabetes have not changed.
Guidance documents
Guidance PDF format
Understanding NICE guidance PDF format
TA53 Arweiniad ar ddefnyddio analogau inswlin hirbarhaol ar gyfer trin clefyd siwgr - inswlin glargin: deall canllawiau NICE
TA53 Diabetes (types 1 and 2) - long acting insulin analogues: summary

Diabetic Medicine Vol 26 Iss 6 2009

We have full text access to Diabetic Medicine. Follow the links below to access the articles. You will need to log in with your NHS Athens password.

Early View (Articles Available Online in Advance of Print) Journal compilation © 2009 Diabetes UK

Editorial
p.573-576
HbA1c: 'The old order changeth'
A. Collier, S. Ghosh, D. F. Davidson, E. S. Kilpatrick
AbstractPublished Online: 17 Apr 2009

Original Articles

Genetics
p. 577-581
Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazone
S. E. Park, E. S. Kang, D. H. Kim, S. K. Kim et al
AbstractPublished Online: 4 Apr 2009

Pathophysiology

p. 582-588
Mechanisms of glucose intolerance in cystic fibrosis
K. Mohan, H. Miller, P. Dyce, R. Grainger et al
AbstractPublished Online: 17 Apr 2009

Metabolism

p. 589-595
Impact of high-fat /low-carbohydrate, high-, low-glycaemic index or low-caloric meals on glucose regulation during aerobic exercise in Type 2 diabetes
A. Ferland, P. Brassard, S. Lemieux et al
AbstractPublished Online: 17 Apr 2009

Epidemiology

p. 596-601
Australia's national trends in the incidence of Type 1 diabetes in 0–14-year-olds, 2000–2006
L. Catanzariti, K. Faulks, L. Moon, A.-M. Waters, J. Flack, M. E. Craig
AbstractPublished Online: 17 Apr 2009

Complications

p. 602-608
Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients
G. Lepore, D. Bruttomesso, M. Bonomo, A. R. Dodesini et al
AbstractPublished Online: 17 Apr 2009

p. 609-616
Impact of diabetes and gender on survival after acute myocardial infarction in the Province of Quebec, Canada—a population-based study
N. Ouhoummane, B. Abdous, V. Émond, P. Poirier
AbstractPublished Online: 2 May 2009

Treatment

p. 617-621
Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials
P. Y. Benhamou, L. Milliat-Guittard, A. Wojtusciszyn, L. Kessler et al
AbstractPublished Online: 17 Apr 2009

p. 22-627
Predicting diabetes distress in patients with Type 2 diabetes: a longitudinal study
L. Fisher, J. T. Mullan, M. M. Skaff, R. E. Glasgow, P. Arean, D. Hessler
AbstractPublished Online: 17 Apr 2009

Care Delivery

p. 628-635
A Ubiquitous Chronic Disease Care system using cellular phones and the internet
H. J. Yoo, M. S. Park, T. N. Kim, S. J. Yang et al
AbstractPublished Online: 1 Jun 2009

Education and Psychological Aspects

p. 636-640
Understanding and beliefs of diabetes in the UK Bangladeshi population
S. M. Choudhury, S. Brophy, R. Williams
AbstractPublished Online: 2 May 2009

p. 641-648
The relationship between depression and diabetes mellitus: findings from the Hertfordshire Cohort Study
R. I. G. Holt, D. I. W. Phillips, K. A. Jameson et al
AbstractPublished Online: 2 May 2009

p. 649-654
Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes1
J. Cuthbertson, S. Patterson, F. P. M. O'Harte, P. M. Bell
AbstractPublished Online: 2 May 2009

Short Report

p. 655-658
Prevalence of known diabetes in German adults aged 25–69 years: results from national health surveys over 15 years
C. Heidemann, L. Kroll, A. Icks, T. Lampert, C. Scheidt-Nave
AbstractPublished Online: 2 May 2009

Letters
Original Observations
p. 659-660
Serum sickness-like reactions associated with type III insulin allergy responding to plasmapheresis
F. Bayraktar, B. Akinci, F. Demirkan et al
AbstractPublished Online: 17 Apr 2009

p. 660-661
Mutations in IAPP and NEUROG3 genes are not a common cause of permanent neonatal/infancy/childhood-onset diabetes
V. Nocerino, C. Colombo, R. Bonfanti, D. Iafusco, F. Barbetti
AbstractPublished Online: 4 Apr 2009

p. 661-663
Insulin resistance and endothelial dysfunction in type 2 diabetic patients with non-alcoholic steatohepatitis
S. Kawashima, M. Suzuki, H. Kaneto, E. Imano, Y. Haruna et al
AbstractPublished Online: 4 Apr 2009

p. 663-664
Diabetic retinopathy in permanent neonatal diabetes due to Kir6.2 gene mutations: the results of a minimum 2-year follow-up after the transfer from insulin to sulphonylurea
T. Klupa, J. Skupien, B. Mirkiewicz-Sieradzka, A. Gach et al
AbstractPublished Online: 3 Apr 2009

Incidence trends for childhood type 1 diabetes in Europe

Incidence trends for childhood type 1 diabetes in Europe during 1989—2003 and predicted new cases 2005—20
http://www.nelm.nhs.uk/en/NeLM-Area/News/2009---May/28/Incidence-trends-for-childhood-type-1-diabetes-in-Europe-during-19892003-and-predicted-new-cases-200520/

Nice guidance

Guidelines:
Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance
http://www.bmj.com/cgi/content/full/338/may22_2/b1668

NICE issues costings for the implementation of guidance on newer agent for type 2 diabetes
http://www.nelm.nhs.uk/en/NeLM-Area/News/2009---May/27/NICE-issues-costings-for-the-implementation-of-guidance-on-newer-agent-for-type-2-diabetes/

Type 2 diabetes - the management of type 2 diabetes (partial update)
http://guidance.nice.org.uk/CG87

Journal of Advanced Nursing Vol 65 No 7 2009

p. 1432-1441
Perceptions of a service redesign by adults living with type 2 diabetes
Joan R.S. McDowell, Kathryn McPhail, Gillian Halyburton, Malcolm Brown, Grace Lindsay
Abstract
Published Online: 5 May 2009